Granahan Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-469,430
| Closed | -$7.63M | – | 177 |
|
|
2022
Q1 | $7.63M | Sell |
469,430
-661,148
| -58% | -$10.8M | 0.19% | 109 |
|
|
2021
Q4 | $15.7M | Buy |
1,130,578
+262,658
| +30% | +$3.64M | 0.32% | 87 |
|
|
2021
Q3 | $12.5M | Buy |
867,920
+413,925
| +91% | +$5.95M | 0.24% | 100 |
|
|
2021
Q2 | $7.18M | Buy |
453,995
+24,093
| +6% | +$381K | 0.13% | 137 |
|
|
2021
Q1 | $4.37M | Buy |
+429,902
| New | +$4.37M | 0.09% | 149 |
|